Target intelligence / Profile preview

Cilia and flagella associated protein 97 pseudogene 1 (CFAP97P1)

Target
CFAP97P1
Molecular classification
Pseudogene, processed pseudogene (typical for pseudogenes related to protein-coding families)
01

Overview

CFAP97 pseudogene 1 (CFAP97P1) is a human pseudogene corresponding to the protein coding gene CFAP97 (Cilia and Flagella Associated Protein 97), which plays roles in cilia and flagella function[1]. Pseudogenes, like CFAP97P1, are typically noncoding genomic sequences resembling functional genes but contain disabling mutations or lack regulatory elements, preventing protein production[5]. While most pseudogenes have no established biological function, growing evidence suggests some may have regulatory effects at the RNA level, acting as decoys for microRNAs or producing regulatory small RNAs, thus indirectly impacting expression of their parental genes or related pathways[2][5]. There is currently no evidence that CFAP97P1 has an established biological or clinical role, nor is it considered a direct therapeutic or diagnostic target. \n\n**Note:** Searching for "CFAP97P1" may occasionally yield information for the protein coding CFAP97 gene, but CFAP97P1 is distinct and does not code for a functional protein[1].

Other names
CFAP97P1cilia and flagella associated protein 97 pseudogene 1cilia and flagella associated protein 97 pseudogene, CFAP97P1
02

Mechanism of action

Not applicable for CFAP97P1. In rare cases, antisense oligonucleotides or RNA-targeted drugs may be developed against pseudogene RNAs associated with disease, but no such mechanisms described for CFAP97P1

03

Biological functions

Possible post-transcriptional regulation of parental gene (CFAP97) expression via microRNA decoy activity or small RNA production (general pseudogene functions)Specific biological functions for CFAP97P1 are not directly reported.
04

Disease associations

No direct disease role assigned to CFAP97P1 itself.More broadly, pseudogenes may act as competitive endogenous RNAs (ceRNAs) or regulators and thereby participate in disease processes including cancer, cardiovascular, or neurological disorders via indirect mechanisms
05

Safety considerations

Not applicable.Pseudogenes generally pose challenges in genetic diagnostics due to sequence homology with parental genesbut do not have a direct safety profile as they are not drug targets.
06

Interacting drugs

None known for CFAP97P1.

1 more in the full profile.

07

Biomarkers

No known biomarker role for CFAP97P1.Some pseudogenes are under investigation as RNA-based biomarkers for disease, but CFAP97P1 has no established utility

Beyond the preview

Go deeper on Cilia and flagella associated protein 97 pseudogene 1 (CFAP97P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilia and flagella associated protein 97 pseudogene 1 (CFAP97P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call